Comparison of Early Effectiveness of Three Different Intervention Methods in Patients with Chronic Orofacial Pain: A Randomized, Controlled Clinical Trial
Table 2
Answer data in simplified scale (analysis of VAS and Sleep and Pain Activity Questionnaire for each question and group).
Group
Pain before treatment
Pain after treatment
No (0)
Mild (1-2)
Moderate (3–6)
Severe (7–10)
No (0)
Mild (1-2)
Moderate (3–6)
Severe (7–10)
n
f
n
f
n
f
n
f
n
f
n
f
n
f
n
f
Q1
Control
0
0
15
0.5
5
0.17
10
0.33
3
0.1
17
0.57
8
0.27
2
0.07
DN
0
0
20
0.67
3
0.1
7
0.23
3
0.1
20
0.67
6
0.2
1
0.03
NSAID
0
0
20
0.67
2
0.07
8
0.27
8
0.27
8
0.27
14
0.47
0
0
Q2
Control
2
0.07
17
0.57
4
0.13
7
0.23
5
0.17
12
0.4
11
0.37
2
0.07
DN
2
0.07
19
0.63
3
0.1
6
0.2
4
0.13
15
0.5
10
0.33
1
0.03
NSAID
1
0.03
15
0.5
4
0.13
10
0.33
10
0.33
5
0.17
13
0.43
2
0.07
Q3
Control
22
0.73
4
0.13
2
0.07
2
0.07
24
0.8
2
0.07
4
0.13
0
0
DN
18
0.6
2
0.07
6
0.2
4
0.13
18
0.6
3
0.1
7
0.23
2
0.07
NSAID
14
0.47
7
0.23
5
0.17
4
0.13
21
0.7
3
0.1
5
0.17
1
0.03
Q4
Control
17
0.57
7
0.23
4
0.13
2
0.07
18
0.6
6
0.2
6
0.2
0
0
DN
8
0.27
8
0.27
11
0.37
3
0.1
12
0.4
4
0.13
11
0.37
3
0.1
NSAID
8
0.27
6
0.2
12
0.4
4
0.13
21
0.7
3
0.1
5
0.17
1
0.03
Q5
Control
2
0.07
11
0.37
8
0.27
9
0.3
8
0.27
10
0.33
9
0.3
3
0.1
DN
2
0.07
12
0.4
4
0.13
12
0.4
6
0.2
12
0.4
7
0.23
5
0.17
NSAID
2
0.07
10
0.33
4
0.13
14
0.47
13
0.43
9
0.3
6
0.2
2
0.07
Q6
Control
9
0.3
10
0.33
6
0.2
5
0.17
14
0.47
7
0.23
6
0.2
3
0.1
DN
5
0.17
8
0.27
9
0.3
8
0.27
10
0.33
8
0.27
8
0.27
4
0.13
NSAID
9
0.3
8
0.27
6
0.2
2
0.07
21
0.7
2
0.07
5
0.17
2
0.07
n, count; f, fraction; Q, question number in the questionnaire.
